Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
81
SBIO Quote, Financials, Valuation and Earnings
Last price:
$53.24
Seasonality move
:
9%
Day range:
$51.26 - $53.49
52-week range:
$22.33 - $54.79
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
11.1K
Avg. volume:
25.9K
1-year change:
92.55%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | -- | -- | -- | -- |
|
ACES
ALPS Clean Energy ETF
|
-- | -- | -- | -- | -- |
|
DRLL
Strive US Energy ETF
|
-- | -- | -- | -- | -- |
|
ENFR
ALPS Alerian Energy Infrastructure ETF
|
-- | -- | -- | -- | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | -- | -- | -- | -- |
|
SHOC
Strive US Semiconductor ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SBIO
ALPS Medical Breakthroughs ETF
|
$53.49 | -- | -- | -- | $1.17 | 0% | -- |
|
ACES
ALPS Clean Energy ETF
|
$33.46 | -- | -- | -- | $0.01 | 0.49% | -- |
|
DRLL
Strive US Energy ETF
|
$38.20 | -- | -- | -- | $0.22 | 2.28% | -- |
|
ENFR
ALPS Alerian Energy Infrastructure ETF
|
$37.89 | -- | -- | -- | $0.39 | 4.05% | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
$41.33 | -- | -- | -- | $0.00 | 0.01% | -- |
|
SHOC
Strive US Semiconductor ETF
|
$73.98 | -- | -- | -- | $0.04 | 0.22% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | 0.055 | -- | -- |
|
ACES
ALPS Clean Energy ETF
|
-- | 0.791 | -- | -- |
|
DRLL
Strive US Energy ETF
|
-- | -0.660 | -- | -- |
|
ENFR
ALPS Alerian Energy Infrastructure ETF
|
-- | -0.182 | -- | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | 0.388 | -- | -- |
|
SHOC
Strive US Semiconductor ETF
|
-- | 1.931 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | -- | -- | -- | -- | -- |
|
ACES
ALPS Clean Energy ETF
|
-- | -- | -- | -- | -- | -- |
|
DRLL
Strive US Energy ETF
|
-- | -- | -- | -- | -- | -- |
|
ENFR
ALPS Alerian Energy Infrastructure ETF
|
-- | -- | -- | -- | -- | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | -- | -- | -- | -- | -- |
|
SHOC
Strive US Semiconductor ETF
|
-- | -- | -- | -- | -- | -- |
ALPS Medical Breakthroughs ETF vs. Competitors
-
Which has Higher Returns SBIO or ACES?
ALPS Clean Energy ETF has a net margin of -- compared to ALPS Medical Breakthroughs ETF's net margin of --. ALPS Medical Breakthroughs ETF's return on equity of -- beat ALPS Clean Energy ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SBIOALPS Medical Breakthroughs ETF-- -- -- ACESALPS Clean Energy ETF-- -- -- -
What do Analysts Say About SBIO or ACES?
ALPS Medical Breakthroughs ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ALPS Clean Energy ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ALPS Medical Breakthroughs ETF has higher upside potential than ALPS Clean Energy ETF, analysts believe ALPS Medical Breakthroughs ETF is more attractive than ALPS Clean Energy ETF.
Company Buy Ratings Hold Ratings Sell Ratings SBIOALPS Medical Breakthroughs ETF0 0 0 ACESALPS Clean Energy ETF0 0 0 -
Is SBIO or ACES More Risky?
ALPS Medical Breakthroughs ETF has a beta of 0.842, which suggesting that the stock is 15.801% less volatile than S&P 500. In comparison ALPS Clean Energy ETF has a beta of 1.407, suggesting its more volatile than the S&P 500 by 40.734%.
-
Which is a Better Dividend Stock SBIO or ACES?
ALPS Medical Breakthroughs ETF has a quarterly dividend of $1.17 per share corresponding to a yield of 0%. ALPS Clean Energy ETF offers a yield of 0.49% to investors and pays a quarterly dividend of $0.01 per share. ALPS Medical Breakthroughs ETF pays -- of its earnings as a dividend. ALPS Clean Energy ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SBIO or ACES?
ALPS Medical Breakthroughs ETF quarterly revenues are --, which are smaller than ALPS Clean Energy ETF quarterly revenues of --. ALPS Medical Breakthroughs ETF's net income of -- is lower than ALPS Clean Energy ETF's net income of --. Notably, ALPS Medical Breakthroughs ETF's price-to-earnings ratio is -- while ALPS Clean Energy ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ALPS Medical Breakthroughs ETF is -- versus -- for ALPS Clean Energy ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SBIOALPS Medical Breakthroughs ETF-- -- -- -- ACESALPS Clean Energy ETF-- -- -- --
-
Which has Higher Returns SBIO or DRLL?
Strive US Energy ETF has a net margin of -- compared to ALPS Medical Breakthroughs ETF's net margin of --. ALPS Medical Breakthroughs ETF's return on equity of -- beat Strive US Energy ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SBIOALPS Medical Breakthroughs ETF-- -- -- DRLLStrive US Energy ETF-- -- -- -
What do Analysts Say About SBIO or DRLL?
ALPS Medical Breakthroughs ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Strive US Energy ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ALPS Medical Breakthroughs ETF has higher upside potential than Strive US Energy ETF, analysts believe ALPS Medical Breakthroughs ETF is more attractive than Strive US Energy ETF.
Company Buy Ratings Hold Ratings Sell Ratings SBIOALPS Medical Breakthroughs ETF0 0 0 DRLLStrive US Energy ETF0 0 0 -
Is SBIO or DRLL More Risky?
ALPS Medical Breakthroughs ETF has a beta of 0.842, which suggesting that the stock is 15.801% less volatile than S&P 500. In comparison Strive US Energy ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SBIO or DRLL?
ALPS Medical Breakthroughs ETF has a quarterly dividend of $1.17 per share corresponding to a yield of 0%. Strive US Energy ETF offers a yield of 2.28% to investors and pays a quarterly dividend of $0.22 per share. ALPS Medical Breakthroughs ETF pays -- of its earnings as a dividend. Strive US Energy ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SBIO or DRLL?
ALPS Medical Breakthroughs ETF quarterly revenues are --, which are smaller than Strive US Energy ETF quarterly revenues of --. ALPS Medical Breakthroughs ETF's net income of -- is lower than Strive US Energy ETF's net income of --. Notably, ALPS Medical Breakthroughs ETF's price-to-earnings ratio is -- while Strive US Energy ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ALPS Medical Breakthroughs ETF is -- versus -- for Strive US Energy ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SBIOALPS Medical Breakthroughs ETF-- -- -- -- DRLLStrive US Energy ETF-- -- -- --
-
Which has Higher Returns SBIO or ENFR?
ALPS Alerian Energy Infrastructure ETF has a net margin of -- compared to ALPS Medical Breakthroughs ETF's net margin of --. ALPS Medical Breakthroughs ETF's return on equity of -- beat ALPS Alerian Energy Infrastructure ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SBIOALPS Medical Breakthroughs ETF-- -- -- ENFRALPS Alerian Energy Infrastructure ETF-- -- -- -
What do Analysts Say About SBIO or ENFR?
ALPS Medical Breakthroughs ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ALPS Alerian Energy Infrastructure ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ALPS Medical Breakthroughs ETF has higher upside potential than ALPS Alerian Energy Infrastructure ETF, analysts believe ALPS Medical Breakthroughs ETF is more attractive than ALPS Alerian Energy Infrastructure ETF.
Company Buy Ratings Hold Ratings Sell Ratings SBIOALPS Medical Breakthroughs ETF0 0 0 ENFRALPS Alerian Energy Infrastructure ETF0 0 0 -
Is SBIO or ENFR More Risky?
ALPS Medical Breakthroughs ETF has a beta of 0.842, which suggesting that the stock is 15.801% less volatile than S&P 500. In comparison ALPS Alerian Energy Infrastructure ETF has a beta of 0.712, suggesting its less volatile than the S&P 500 by 28.805%.
-
Which is a Better Dividend Stock SBIO or ENFR?
ALPS Medical Breakthroughs ETF has a quarterly dividend of $1.17 per share corresponding to a yield of 0%. ALPS Alerian Energy Infrastructure ETF offers a yield of 4.05% to investors and pays a quarterly dividend of $0.39 per share. ALPS Medical Breakthroughs ETF pays -- of its earnings as a dividend. ALPS Alerian Energy Infrastructure ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SBIO or ENFR?
ALPS Medical Breakthroughs ETF quarterly revenues are --, which are smaller than ALPS Alerian Energy Infrastructure ETF quarterly revenues of --. ALPS Medical Breakthroughs ETF's net income of -- is lower than ALPS Alerian Energy Infrastructure ETF's net income of --. Notably, ALPS Medical Breakthroughs ETF's price-to-earnings ratio is -- while ALPS Alerian Energy Infrastructure ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ALPS Medical Breakthroughs ETF is -- versus -- for ALPS Alerian Energy Infrastructure ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SBIOALPS Medical Breakthroughs ETF-- -- -- -- ENFRALPS Alerian Energy Infrastructure ETF-- -- -- --
-
Which has Higher Returns SBIO or PSCH?
Invesco S&P SmallCap Health Care ETF has a net margin of -- compared to ALPS Medical Breakthroughs ETF's net margin of --. ALPS Medical Breakthroughs ETF's return on equity of -- beat Invesco S&P SmallCap Health Care ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SBIOALPS Medical Breakthroughs ETF-- -- -- PSCHInvesco S&P SmallCap Health Care ETF-- -- -- -
What do Analysts Say About SBIO or PSCH?
ALPS Medical Breakthroughs ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco S&P SmallCap Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ALPS Medical Breakthroughs ETF has higher upside potential than Invesco S&P SmallCap Health Care ETF, analysts believe ALPS Medical Breakthroughs ETF is more attractive than Invesco S&P SmallCap Health Care ETF.
Company Buy Ratings Hold Ratings Sell Ratings SBIOALPS Medical Breakthroughs ETF0 0 0 PSCHInvesco S&P SmallCap Health Care ETF0 0 0 -
Is SBIO or PSCH More Risky?
ALPS Medical Breakthroughs ETF has a beta of 0.842, which suggesting that the stock is 15.801% less volatile than S&P 500. In comparison Invesco S&P SmallCap Health Care ETF has a beta of 0.927, suggesting its less volatile than the S&P 500 by 7.277%.
-
Which is a Better Dividend Stock SBIO or PSCH?
ALPS Medical Breakthroughs ETF has a quarterly dividend of $1.17 per share corresponding to a yield of 0%. Invesco S&P SmallCap Health Care ETF offers a yield of 0.01% to investors and pays a quarterly dividend of $0.00 per share. ALPS Medical Breakthroughs ETF pays -- of its earnings as a dividend. Invesco S&P SmallCap Health Care ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SBIO or PSCH?
ALPS Medical Breakthroughs ETF quarterly revenues are --, which are smaller than Invesco S&P SmallCap Health Care ETF quarterly revenues of --. ALPS Medical Breakthroughs ETF's net income of -- is lower than Invesco S&P SmallCap Health Care ETF's net income of --. Notably, ALPS Medical Breakthroughs ETF's price-to-earnings ratio is -- while Invesco S&P SmallCap Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ALPS Medical Breakthroughs ETF is -- versus -- for Invesco S&P SmallCap Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SBIOALPS Medical Breakthroughs ETF-- -- -- -- PSCHInvesco S&P SmallCap Health Care ETF-- -- -- --
-
Which has Higher Returns SBIO or SHOC?
Strive US Semiconductor ETF has a net margin of -- compared to ALPS Medical Breakthroughs ETF's net margin of --. ALPS Medical Breakthroughs ETF's return on equity of -- beat Strive US Semiconductor ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SBIOALPS Medical Breakthroughs ETF-- -- -- SHOCStrive US Semiconductor ETF-- -- -- -
What do Analysts Say About SBIO or SHOC?
ALPS Medical Breakthroughs ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Strive US Semiconductor ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ALPS Medical Breakthroughs ETF has higher upside potential than Strive US Semiconductor ETF, analysts believe ALPS Medical Breakthroughs ETF is more attractive than Strive US Semiconductor ETF.
Company Buy Ratings Hold Ratings Sell Ratings SBIOALPS Medical Breakthroughs ETF0 0 0 SHOCStrive US Semiconductor ETF0 0 0 -
Is SBIO or SHOC More Risky?
ALPS Medical Breakthroughs ETF has a beta of 0.842, which suggesting that the stock is 15.801% less volatile than S&P 500. In comparison Strive US Semiconductor ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SBIO or SHOC?
ALPS Medical Breakthroughs ETF has a quarterly dividend of $1.17 per share corresponding to a yield of 0%. Strive US Semiconductor ETF offers a yield of 0.22% to investors and pays a quarterly dividend of $0.04 per share. ALPS Medical Breakthroughs ETF pays -- of its earnings as a dividend. Strive US Semiconductor ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SBIO or SHOC?
ALPS Medical Breakthroughs ETF quarterly revenues are --, which are smaller than Strive US Semiconductor ETF quarterly revenues of --. ALPS Medical Breakthroughs ETF's net income of -- is lower than Strive US Semiconductor ETF's net income of --. Notably, ALPS Medical Breakthroughs ETF's price-to-earnings ratio is -- while Strive US Semiconductor ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ALPS Medical Breakthroughs ETF is -- versus -- for Strive US Semiconductor ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SBIOALPS Medical Breakthroughs ETF-- -- -- -- SHOCStrive US Semiconductor ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
49
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 27x
Alerts
Buy
51
AAOI alert for Apr 5
Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.
Buy
59
SBAC alert for Apr 5
SBA Communications Corp. [SBAC] is up 18.96% over the past day.
Buy
55
VSAT alert for Apr 5
ViaSat, Inc. [VSAT] is up 18.73% over the past day.
